Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion - Wikidata - wikimedia - TriplyDB

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

http://www.wikidata.org/entity/Q24648979

about

Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults Sumatriptan plus naproxen for acute migraine attacks in adults Naproxen with or without an antiemetic for acute migraine headaches in adults Sumatriptan plus naproxen for acute migraine headaches in adults Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.A novel method for modeling facial allodynia associated with migraine in awake and freely moving rats Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches.Modelling headache and migraine and its pharmacological manipulation Targeting TRP channels for novel migraine therapeutics.Sensitization of meningeal nociceptors: inhibition by naproxen.The blood-brain barrier in migraine treatment.Allodynia in migraine: frequent random association or unavoidable consequence?Animal models of headache: from bedside to bench and back to bedside.The paradoxical effects of analgesics and the development of chronic migraine.The science of migraine.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.COX inhibitors for the treatment of migraine.Drug safety in acute migraine treatment.Blockade of 5-HT3 receptors with granisetron does not affect trigeminothalamic nociceptive transmission in rats: implication for migraine.Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.Two TRPV1 receptor antagonists are effective in two different experimental models of migraine.Remarks on an educational training course on headache.Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT).Neurophysiological markers of central sensitisation in the trigeminal pathway and their modulation by the cyclo-oxygenase inhibitor ketorolac.Triptan-induced latent sensitization: a possible basis for medication overuse headache.Nitroglycerin provocation in normal subjects is not a useful human migraine model?Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats.Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma.Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura

P2860

Q24185878-D8D14BCF-3E9F-4FF0-890E-076B7B1BECE7 Q24202970-7741FC85-8172-434E-92CE-139107CD0A07 Q24202983-C6BBDDCB-DE6A-4B62-8C7D-E111AA76A632 Q24235044-9702CBAC-FD1A-4CEA-927E-C699B6ED57C3 Q30465785-4E406C1C-A911-4406-8142-CB0D6819A745 Q30466408-D53435A7-9AD4-4230-AAB1-286A2B35231A Q33624316-1B2C9CBC-77CA-4C28-8091-F6C9EB7A1D3F Q33836100-92BEA957-48E2-4E60-858F-1484CC364848 Q33978721-6880ABF8-81CB-4C04-8B41-189A4058585F Q34180539-A6067CBE-D87C-47B6-9528-F65EA7E7DD02 Q34372828-BACB134F-E52C-4408-883D-81F6F5D71A48 Q34407137-2594A973-7310-4889-921C-955C00671E3A Q34555756-3E2A96F1-B287-4670-9ED9-F928E21D36C4 Q37181373-2E1283E4-98D1-40AC-82AF-A8983DCE28DA Q37252452-EDF8089A-2AF6-4DE9-A097-005D93595A83 Q37409505-FF9FA02A-DF13-43F8-A65E-A25A2F45C846 Q37699421-2CCCD219-84C4-465E-9D34-80CEC5929F37 Q37900861-051DA499-C31A-4647-8622-39C513CBC227 Q37986274-8D75B3F1-1C47-493C-83A1-A9DB7B5ED595 Q38129436-896CB29D-8AF4-4878-9903-6FA11842739D Q38227997-135D5230-A270-40B7-93A9-B4920462A858 Q38378898-B5309DA3-9C4B-4F81-B976-57F49D44407C Q38602532-60C94880-2144-46F6-ADBB-BF3FC8A71386 Q39117083-5A2AC1E9-8CBE-4A0B-B8F6-9B48A26CFC00 Q39345858-6C87AA2A-D025-4010-9D0F-58659ABDC1A0 Q41440081-EA113454-46CB-4D8A-8FEF-14BB8F49190A Q41963362-1A5896AD-10DF-48F6-B741-94F0FD2C6D82 Q42854066-092252FC-091A-4725-B969-2A7C27B0795C Q42882632-94DD68A0-B9FE-44CB-AAFD-87E6696A4764 Q43107488-690E924D-4308-4A99-84D9-8CB1175E6F7C Q43279154-1FAD0A77-547E-4AA3-8E36-6763BE7466B7 Q45131483-FC233200-7F70-4135-A3B3-7B25D3D51DB5 Q46051400-3964361D-FEBB-4D91-A574-BA10FB3339C1 Q46550880-AF77931C-982F-4971-8ACE-CC03A63E7853 Q47327177-D3B192A6-EB4E-4887-9F04-EF5D9BFF8BB0 Q52656846-6858ABB3-9254-415C-AE3E-747F76D39AB3 Q57023979-B75554CD-A76D-47C1-8BA8-742FD4B398A2

P2860

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

http://www.wikidata.org/entity/Q24648979

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Sensitization of central trige ...... intravenous naproxen infusion

@ast

Sensitization of central trige ...... intravenous naproxen infusion

@en

Sensitization of central trige ...... intravenous naproxen infusion

@nl

type

label

Sensitization of central trige ...... intravenous naproxen infusion

@ast

Sensitization of central trige ...... intravenous naproxen infusion

@en

Sensitization of central trige ...... intravenous naproxen infusion

@nl

prefLabel

Sensitization of central trige ...... intravenous naproxen infusion

@ast

Sensitization of central trige ...... intravenous naproxen infusion

@en

Sensitization of central trige ...... intravenous naproxen infusion

@nl

P1433

Q24648979-A4DEDFAB-749F-4A71-91B6-F397EAEB326E

P1476

Q24648979-7D41DFB7-E690-4896-B3AA-272F0EA6F495

P2093

Q24648979-168DC9C2-02D5-44DE-951C-488601D9881F

Q24648979-39F84DB3-60C8-42A6-8B36-AC49456055AC

Q24648979-66FBC2EB-7FB5-4713-84F2-392D9F99855A

Q24648979-A2DFD44F-9B1F-469D-B74D-AB26450841C7

Q24648979-CD0007C8-B7FF-4483-8D50-CEDA207F76F2

P2860

Q24648979-07A14654-AF44-44F4-B178-5CFBC0166D3B

Q24648979-0E3D8753-B366-4A35-87AE-A7220E98CCF3

Q24648979-15CB07E7-B7CD-4CE7-9E82-6EC0053D0A7D

Q24648979-27CE4949-7549-4DBD-AB7B-4F3D9F61E29E

Q24648979-50B1966D-BCB6-40D2-85AB-68F20411FDB9

Q24648979-69009C55-F763-42EE-AACA-B4E5DB10C6AD

Q24648979-6905880C-0CFA-4F68-B6C6-738EA16C8E93

Q24648979-71602509-FE47-47F1-881C-1B4D621AC36A

Q24648979-723DDBFB-F63D-4A20-8B53-D4A6E441D5DD

Q24648979-78538D31-1100-49B4-9763-49DE42A3C92B

P304

Q24648979-4F806FA8-70CF-4D99-A35A-F94D27C59D85

P31

Q24648979-00AFA1C3-3D6B-47AC-B388-9A466187C66A

P356

Q24648979-30A1920A-A109-44BA-BF94-3E018E47B144

P407

Q24648979-8D13BDA8-0BCE-48E6-AD42-8A5EF901AF3B

P433

Q24648979-0CE44DD2-82BA-496F-AB4B-C491573F3ADF

P478

Q24648979-1864B71D-28F5-443D-936E-4CE43A1C11C4

P50

Q24648979-ABAE1B23-1C13-4E29-8BA6-78938AF4828E

P577

Q24648979-29AC3388-2EA0-4406-918B-8E222D7B1D6E

P5875

Q24648979-83D1C576-19AE-41B7-B1A4-BC8E068CB160

P698

Q24648979-081329E5-2A2A-4E98-853A-273619130C61

P932

Q24648979-FD52A344-5850-48FA-9547-6B10EF360AAA

P356

J.NEUROSCIENCE.2007.04.064

P1433

P1476

Sensitization of central trige ...... intravenous naproxen infusion

@en

P2093

B Kosaras

http://www.w3.org/2001/XMLSchema#string

D Levy

http://www.w3.org/2001/XMLSchema#string

R Burstein

http://www.w3.org/2001/XMLSchema#string

V Kainz

http://www.w3.org/2001/XMLSchema#string

X-C Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors

Direct activation of rat spinal dorsal horn neurons by prostaglandin E2.

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.

Central sensitization and LTP: do pain and memory share similar mechanisms?

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro

Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists.

Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.

Prostaglandin-induced neuropeptide release from spinal cord.

Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro.

P304

573-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROSCIENCE.2007.04.064

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

Moshe Jakubowski

P577

2007-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6186660

http://www.w3.org/2001/XMLSchema#string

P698

17651900

http://www.w3.org/2001/XMLSchema#string

P932

2710388

http://www.w3.org/2001/XMLSchema#string